Greenskeeper Asset Management said Elevance Health contributed strongly to its portfolio in the second quarter of 2026, gaining 32.1%, and that the health insurer's operating margins may bottom this year before an earnings recovery in 2027. The firm noted that profitability has begun to improve after a period of elevated medical cost inflation in government-sponsored plans, with cost trends stabilizing and government reimbursement updates proving more favorable than expected. Greenskeeper expects disciplined repricing and better alignment between premiums and medical expenses to drive the recovery, while Elevance's commercial health insurance franchise continues to perform well and provides a durable foundation for long-term earnings power. Elevance Health shares closed at $382.77 on August 3, 2026, with a market capitalization of $81.54 billion, and have gained 38.48% over the past 52 weeks.
Elevance Health IncGreenskeeper expects operating margins to bottom in 2026 and recover in 2027, citing stabilizing costs and favorable government reimbursement, driving earnings recovery.